Suven Life Sciences
Business Services · India · 11-50 Employees
View Company Info for Free
Overview
Headquarters
8-2-334 Sde Serene Chambers 6th Floor Ro...Phone Number
+91 4023541142Website
www.suven.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
1
1
1
1
1
About Suven Life Sciences
Suven, Inc. a Delaware company, a wholly owned subsidiary of Suven Life Sciences Limited, India, is a clinical-stage biopharmaceutical company focused on acquisition, development and commercialization of novel therapeutics for the treatment of neurodegenerative disorders. Suven Life Sciences' discovery research programs are focused on discovering and developing novel pharmaceutical products, which are first in class or best in class CNS therapies through the use of GPCR targets, having world wide patents. Suven has 3 clinical stage compounds, a Phase 2 initiated candidate SUVN-502, Phase 1 completed candidate SUVN-G3031 and Phase 1 initiated candidate SUVN-D-4010 for Alzheimer's disease and Schizophrenia. In addition, the Company has Ten (10) internally-discovered therapeutic drug candidates currently in pre-clinical stage of development targeting conditions such as ADHD, dementia, depression, Huntington's disease, Parkinson's disease and pain.Explore more
Suven Life Sciences Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Suven Life Sciences your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Suven Life Sciences is spiking on competitors!
Suven Life Sciences, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Suven Life Sciences recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Suven Life Sciences has new funding data
Click to see if Suven Life Sciences had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Suven Life Sciences
Product Launch: Get notified when Suven Life Sciences launches new products
Check if Suven Life Sciences has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Find VP level buyers at Suven Life Sciences
Find more new buyers
Company Profile Activity
Activity Insights
Suven Life Sciences is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Suven Life Sciences is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Suven Life Sciences.
Suven Life Sciences Tech Stack
A closer look at the technologies used by Suven Life Sciences
Most Recent Scoops
Project
Laboratory Operations, Medical Research, Clinical Operations
Project
Laboratory Operations, Medical Research, Clinical Operations
Project
Laboratory Operations, Medical Research, Clinical Operations
Project
Laboratory Operations, Medical Research, Clinical Operations
Earnings
Product Marketing, Product Launch
Suven Life Sciences News & Media
Narcolepsy Market Analysis, Market Size, Epidemiology, and Competitive Analysis of Leading Companies Including Takeda, Suven Life Sciences Limited, Axsome Therapeutics, Inc., Avadel, and Others by DelveInsight
According to DelveInsight's' estimates, the narcolepsy market in the 7MM is expected to show good positive growth, during the forecast period (2023–2032), mainly attributed to new product launches, robust pipeline of emerging therapies, and improved diagnosis of narcolepsy LAS VEGAS, Oct....Advent to acquire majority holding in Suven Pharma for $762m
Advent to acquire majority holding in Suven Pharma for $762m Submitted 29/12/2022 - 11:07am Private equity major Advent International, is to acquire a controlling stake in India-based Suven Pharmaceuticals Ltd for at least $762 million, according to a report by Bloomberg, triggering an open offer to purchase additional shares in the business. The report cites an exchange regulatory filing as revealing that advent has agreed to acquire a 50.1% stake in Suven from the JastiAdvent Buys Majority Stake in Suven Pharma for $762M - Mergers & Acquisitions
Advent’s key investment areas will continue to be healthcare, consumer, financial services and information technology in India.Top headlines: Venugopal Dhoot arrested, Advent buys stake in Suven, & more
Business Standard brings you the top headlines at this hour
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Suven Life Sciences
Sign Up For FreeTo access detailed company insights
Suven, Inc. a Delaware company, a wholly owned subsidiary of Suven Life Sciences Limited, India, is a clinical-stage biopharmaceutical company focused on acquisition, development and commercialization of novel therapeutics for the treatment of neurodegenerative disorders. Suven Life Sciences' discovery research programs are focused on discovering a... Read More
